Synthetic peptide corresponding to residues in C terminus of human ELK1.
This product is a recombinant rabbit monoclonal antibody.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Our Abpromise guarantee covers the use of ab32106 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/500. Detects a band of approximately 62 kDa (predicted molecular weight: 45 kDa).|
|ChIP||Use at an assay dependent concentration. PubMed: 22589737|